REATA PHARMACEUTICALS INC Revenue
REATA PHARMACEUTICALS INC reported Revenue of $32.39 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2018-05-08
- REATA PHARMACEUTICALS INC revenues for the quarter ending 2018-03-31 was $32.39M, a 154.41% increase year-over-year.
- REATA PHARMACEUTICALS INC revenues for the quarter ending 2017-12-31 was $9.96M, a 20.30% decline year-over-year.
- REATA PHARMACEUTICALS INC revenues for the quarter ending 2017-09-30 was $12.56M, a 0.05% increase year-over-year.
- REATA PHARMACEUTICALS INC revenues for the quarter ending 2017-06-30 was $12.81M, a 3.56% increase year-over-year.
- REATA PHARMACEUTICALS INC revenues for fiscal 2017 was $48.06M, a 3.61% decline from fiscal 2016.
- REATA PHARMACEUTICALS INC revenues for fiscal 2016 was $49.86M, a 0.92% decline from fiscal 2015.
- REATA PHARMACEUTICALS INC revenues for fiscal 2015 was $50.32M, a 3.15% decline from fiscal 2014.
- REATA PHARMACEUTICALS INC revenues for fiscal 2014 was $51.95M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2018-03-31 | $32.39M 10-Q · filed 2018-05-08 | $42.35M derived: sum of 2 quarters · filed 2018-05-08 | $54.91M derived: sum of 3 quarters · filed 2018-05-08 | $67.72M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | $9.96M 10-K · filed 2018-03-02 | $22.52M derived: sum of 2 quarters · filed 2018-03-02 | $35.33M derived: sum of 3 quarters · filed 2018-03-02 | $48.06M 10-K · filed 2018-03-02 |
| 2017-09-30 | $12.56M 10-K · filed 2018-03-02 | $25.36M derived: sum of 2 quarters · filed 2018-03-02 | $38.09M 10-Q · filed 2017-11-13 | $50.60M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-06-30 | $12.81M 10-K · filed 2018-03-02 | $25.54M 10-Q · filed 2017-08-14 | $38.04M derived: sum of 3 quarters · filed 2018-05-08 | $50.59M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-03-31 | $12.73M 10-Q · filed 2018-05-08 | $25.23M derived: sum of 2 quarters · filed 2018-05-08 | $37.78M derived: sum of 3 quarters · filed 2018-05-08 | $50.15M derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | $12.50M 10-K · filed 2018-03-02 | $25.05M derived: sum of 2 quarters · filed 2018-03-02 | $37.42M derived: sum of 3 quarters · filed 2018-03-02 | $49.86M 10-K · filed 2018-03-02 |
| 2016-09-30 | $12.55M 10-K · filed 2018-03-02 | $24.92M derived: sum of 2 quarters · filed 2018-03-02 | $37.35M 10-Q · filed 2017-11-13 | $49.88M derived: sum of 4 quarters · filed 2018-03-02 |
| 2016-06-30 | $12.37M 10-K · filed 2018-03-02 | $24.80M 10-Q · filed 2017-08-14 | $37.33M derived: sum of 3 quarters · filed 2018-03-02 | $49.83M derived: sum of 4 quarters · filed 2018-03-02 |
| 2016-03-31 | $12.44M 10-K · filed 2018-03-02 | $24.96M derived: sum of 2 quarters · filed 2018-03-02 | $37.46M derived: sum of 3 quarters · filed 2018-03-02 | $49.83M derived: sum of 4 quarters · filed 2018-03-02 |
| 2015-12-31 | $12.53M 10-K · filed 2017-03-03 | $25.02M derived: sum of 2 quarters · filed 2017-03-03 | $37.39M derived: sum of 3 quarters · filed 2017-03-03 | $50.32M 10-K · filed 2018-03-02 |
| 2015-09-30 | $12.50M 10-K · filed 2017-03-03 | $24.86M derived: sum of 2 quarters · filed 2017-03-03 | $37.79M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $12.37M 10-K · filed 2017-03-03 | $25.29M 10-Q · filed 2016-08-11 | ||
| 2015-03-31 | $12.93M 10-K · filed 2017-03-03 | |||
| 2014-12-31 | $51.95M 10-K · filed 2017-03-03 |